Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770470443441 Cache Key: cqdTagPageBySlug:diffuse-large-b-cell-lymphoma fetchCache[cqdTagPageBySlug:diffuse-large-b-cell-lymphoma].expirationTime: falsey fetchCache[cqdTagPageBySlug:diffuse-large-b-cell-lymphoma]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: 8367 -- Key: cqdTagPageBySlug:shih-chieh-jeff-chueh, seconds remaining: -4431 -- Key: cqdTagPageBySlug:jean-paul-achkar, seconds remaining: -4357 -- Key: cqdPostsByTag:cqd-migrated-tag-1522,1,10, seconds remaining: -4355 -- Key: cqdTagPageBySlug:glioma-stem-cell, seconds remaining: -4260 -- Key: cqdPostsByTag:cqd-migrated-tag-2893,1,10, seconds remaining: -4276 -- Key: cqdPostsByTag:cqd-migrated-tag-19670,1,10, seconds remaining: -4188 -- Key: cqdTagPageBySlug:noninvasive-scores, seconds remaining: -899 -- Key: cqdPostsByTag:cqd-migrated-tag-17522,1,10, seconds remaining: -825 -- Key: cqdTagPageBySlug:perineal-laceration, seconds remaining: 2357 -- Key: cqdPostsByTag:cqd-migrated-tag-18930,1,10, seconds remaining: 2425 -- Key: cqdTagPageBySlug:glioma, seconds remaining: 2660 -- Key: cqdPostsByTag:cqd-migrated-tag-17826,1,10, seconds remaining: 2732 -- Key: cqdTagPageBySlug:diabetic-neuropathy, seconds remaining: 3364 -- Key: cqdPostsByTag:cqd-migrated-tag-17739,1,10, seconds remaining: 3435 -- Key: cqdTagPageBySlug:cardiac-fibroblasts, seconds remaining: 3729 -- Key: cqdPostsByTag:cqd-migrated-tag-18386,1,10, seconds remaining: 3793 -- Key: cqdTagPageBySlug:wcog-at-acg2017, seconds remaining: 4122 -- Key: cqdPostsByTag:cqd-migrated-tag-17508,1,10, seconds remaining: 4187 -- Key: cqdTagPageBySlug:body-weight-regulation, seconds remaining: 5541 -- Key: cqdPostsByTag:cqd-migrated-tag-24609,1,10, seconds remaining: 5615 -- Key: cqdTagPageBySlug:immune-checkpoint-inhibitor, seconds remaining: 8367 -- Key: cqdPostsByTag:cqd-migrated-tag-21039,1,10, seconds remaining: 8433 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:diffuse-large-b-cell-lymphoma - retrieving from Sanity CCCache.dataFetchCount: 5037 Cache cleanup seconds remaining: 15569
Advertisement
Advertisement
Tag: diffuse large b-cell lymphoma
Age alone should not rule out patients from potentially curative treatment
Study measures real-world outcomes for relapsed or refractory large B-cell lymphoma
Optimized responses in transplant- and CAR T-cell therapy-eligible patients
CAR T-cell therapy, bispecifics and antibody drug conjugates have changed disease management
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic Cancer Institute takes multi-faceted approach to ensuring clinical trials representation
Dispelling myths and sharing practical experiences
Distinct molecular features found in five subtypes of disease
Patients who relapse early after first-line chemotherapy are often, but not always, refractory to second-line chemotherapy
A New Standard of Care in Relapsed/Refractory Large B-Cell Lymphoma
Improving safety, efficacy and access for emerging therapies
Rendered: Sat Feb 07 2026 13:20:43 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.
Search
